Gruschen R Veldtman
Overview
Explore the profile of Gruschen R Veldtman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
972
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Padfield G, Wright G, Veldtman G, Walker N, Danton M, Connelly D
HeartRhythm Case Rep
. 2025 Feb;
11(2):133-137.
PMID: 40018305
No abstract available.
2.
Cifra B, Cordina R, Gauthier N, Murphy L, Pham T, Veldtman G, et al.
J Am Heart Assoc
. 2025 Jan;
14(4):e038200.
PMID: 39782908
Survivorship from congenital heart disease has improved rapidly secondary to advances in surgical and medical management. Because these patients are living longer, treatment and disease surveillance targets have shifted toward...
3.
Miranda W, Jain C, Connolly H, Van De Bruaene A, Veldtman G, Egbe A
CJC Pediatr Congenit Heart Dis
. 2024 Dec;
3(5):225-228.
PMID: 39619005
We hypothesized that phenotyping patients using a combination of resting peripheral venous pressure (PVP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) would predict invasive Fontan haemodynamics. Accordingly, 35 adults with a...
4.
Fontan circulation and systemic disease - a retrospective cohort analysis over 35 years of follow-up
Veldtman G, Abualsaud A, Cohen S, Ordonez M, Guo L, Li C, et al.
Am Heart J
. 2024 Oct;
279:40-49.
PMID: 39423992
Background: The Fontan operation provides lifesaving palliation for individuals with single ventricle (SV) physiology. Given recent concerns of systemic disease (SD) for patients with a Fontan circulation, we sought to...
5.
Neijenhuis R, MacDonald S, Zemrak F, Mertens B, Dinsdale A, Hunter A, et al.
J Am Coll Cardiol
. 2024 Mar;
83(15):1403-1414.
PMID: 38530688
Background: Heart failure (HF) is the principal cause of morbidity and mortality in adults with congenital heart disease (ACHD). Robust evidence-based treatment options are lacking. Objectives: This study aims to...
6.
Bigelow A, Riggs K, Morales D, Opotowsky A, Lubert A, Dillman J, et al.
Pediatr Cardiol
. 2023 Apr;
45(7):1389-1397.
PMID: 37084132
After Fontan operation, decreased venous capacitance and venoconstriction are adaptive mechanisms to maintain venous return and cardiac output. The consequent higher venous pressure may adversely impact end-organ function, exercise capacity...
7.
Dimopoulos K, Constantine A, Clift P, Condliffe R, Moledina S, Jansen K, et al.
Circulation
. 2023 Jan;
147(5):425-441.
PMID: 36716257
Cardiovascular disease is a leading cause of morbidity and mortality in individuals with Down syndrome. Congenital heart disease is the most common cardiovascular condition in this group, present in up...
8.
Al Najashi K, Najashi N, Ahmed T, Abdelnaeem R, Alolit S, Zuaybir A, et al.
Cardiol Young
. 2022 Oct;
33(10):1834-1839.
PMID: 36258282
Background And Hypotheses: High venous pressures and associated hepatic congestion are important drivers for Fontan-associated liver disease. The prognostic significance of hepatomegaly as a marker of congestion however is not...
9.
Vriz O, Feras K, Alamri M, Blassy B, Almozel A, Smith M, et al.
J Cardiovasc Echogr
. 2022 Jun;
32(1):38-46.
PMID: 35669131
Background: Rheumatic mitral valve (MV) stenosis is associated with progressive left atrial (LA) fibrosis and functional impairment, Pulmonary artery systolic pressure (PASP) and right ventricular (RV) dysfunction. The aims of...
10.
Mackie A, Veldtman G, Thorup L, Hjortdal V, Dori Y
Can J Cardiol
. 2022 Mar;
38(7):988-1001.
PMID: 35314335
Plastic bronchitis (PB) and protein-losing enteropathy (PLE) are rare but potentially devastating complications of the Fontan circulation. PB occurs in ∼4% of Fontan patients, typically presents within 2 to 3...